Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implication of Albuminuria Reduction and Other Cardiorenal Effects on The Risk of Heart Failure in Patients With CKD and T2D

NCT07719621 is registered in ClinicalTrials.gov with Aeterna Medical Solutions SL as lead sponsor.

NCT NCT07719621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07719621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implication of Albuminuria Reduction and Other Cardiorenal Effects on The Risk of Heart Failure in Patients With CKD and T2D
Lead sponsor
Aeterna Medical Solutions SL
Phase
Observational
Overall status
Completed
Start date
August 7, 2026
Completion date
August 20, 2026
Enrollment
100,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ckd - chronic kidney disease, diabetes mellitus type 2